Is it feasible to conduct a randomised controlled trial of pre-habilitation in multiple myeloma (MM) patients awaiting autologous haematopoietic stem-cell transplantation (AHSCT)? The PREeMPT study

Authors
Publication date
3 September 2018
Publisher
Springer Nature

Abstract

Abstract is not available.

    Similar works

    Full text

    thumbnail-image

    Available Versions

    Sheffield Hallam University Research Archive

    redirect
    oaioai:shura.shu.ac.uk:24615
    Last time updated on 07/08/2019